Apraclonidine ophthalmic
Generic name: Apraclonidine Ophthalmic
Brand names: Iopidine
Dosage form: ophthalmic solution (0.5%; 1%)
Drug class:
Ophthalmic glaucoma agents
Usage of Apraclonidine ophthalmic
Apraclonidine reduces the amount of fluid in the eye, which decreases pressure inside the eye.
Apraclonidine ophthalmic (for the eyes) is used short term to treat or prevent high pressure inside the eye.
Apraclonidine ophthalmic may also be used for other purposes not listed in this medication guide.
Apraclonidine ophthalmic side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Apraclonidine ophthalmic may cause serious side effects. Call your doctor at once if you have:
Common side effects of apraclonidine ophthalmic may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Apraclonidine ophthalmic
You should not use this medicine if you are allergic to apraclonidine or to clonidine (Catapres).
Do not use apraclonidine ophthalmic if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.
To make sure this apraclonidine is safe for you, tell your doctor if you have ever had:
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant.
It is not known whether apraclonidine ophthalmic passes into breast milk or if it could harm a nursing baby. You should not breast-feed on the day you are treated with this medicine.
Relate drugs
- Alphagan P
- Apraclonidine
- Apraclonidine ophthalmic
- Azopt
- Combigan
- Cosopt
- Cosopt Ocumeter
- Cosopt Ocumeter Plus
- Cosopt PF
- Betagan
- Betaxolol ophthalmic
- Betimol
- Betoptic S
- Bimatoprost
- Bimatoprost ophthalmic
- Bimatoprost ophthalmic implant
- Brimonidine and brinzolamide
- Brimonidine and brinzolamide ophthalmic
- Brimonidine and timolol
- Brimonidine and timolol ophthalmic
- Brimonidine ophthalmic
- Brinzolamide
- Brinzolamide ophthalmic
- Carbachol ophthalmic
- Carteolol
- Carteolol ophthalmic
- Dipivefrin
- Dorzolamide
- Dorzolamide and timolol
- Dorzolamide and timolol ophthalmic
- Dorzolamide ophthalmic
- Durysta
- Echothiophate iodide ophthalmic
- Epinephrine (Ophthalmic)
- Eserine
- Iopidine
- Isopto Carbachol
- Isopto Carpine
- Isopto Eserine
- Istalol
- Izba
- Latanoprost
- Latanoprost and netarsudil ophthalmic
- Latanoprost ophthalmic
- Latanoprostene bunod
- Latanoprostene bunod ophthalmic
- Levobunolol
- Levobunolol ophthalmic
- Lumigan
- Metipranolol
- Miostat
- Netarsudil
- Netarsudil and latanoprost
- Netarsudil ophthalmic
- Ocu-Carpine
- Ocupress
- Ocusert Pilo
- Omidenepag isopropyl
- Omlonti
- Optipranolol
- Phospholine Iodide
- Pilocar
- Pilocarpine ophthalmic
- Pilopine-HS
- Propine
- Rescula
- Rhopressa
- Rocklatan
- Simbrinza
- Tafluprost
- Tafluprost ophthalmic
- Timolol ophthalmic
- Timoptic
- Timoptic Ocudose
- Timoptic Ocumeter
- Timoptic Ocumeter Plus
- Timoptic-XE Ocumeter
- Timoptic-XE Ocumeter Plus
- Travatan Z
- Travoprost
- Travoprost ophthalmic
- Trusopt
- Trusopt Ocumeter
- Trusopt Ocumeter Plus
- Unoprostone
- Vyzulta
- Xalatan
- Xelpros
- Zioptan
How to use Apraclonidine ophthalmic
Usual Adult Dose for Glaucoma:
0.5% Solution: 1 to 2 drops instilled in the affected eye(s) 3 times per dayComments:-When used concomitantly with other ophthalmic drugs, an approximate 5-minute interval between instillation of each medication should be followed to prevent washout of the previous dose.-Use of this drug may not significantly reduce intraocular pressure (IOP) if this drug is added to a regimen already containing 2 drugs as part of the maximally tolerated medical therapy.-Patients on maximally tolerated medical therapy who are treated to delay surgery should have frequent follow up examinations and treatment should be discontinued if the IOP rises significantly.Use: Short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional IOP reduction
Usual Adult Dose for Postoperative Increased Intraocular Pressure:
1% Ophthalmic Solution: 1 drop instilled into the eye scheduled for operation 1 hour before initiating anterior segment laser surgery, AND THEN 1 drop should be instilled into the same eye immediately upon completion of the laser surgical procedureComment: A separate container should be used for each dose and discarded after use.Use: Control or prevent post-surgical elevations in IOP that occur in patients after argon laser trabeculoplasty, argon laser iridotomy, or neodymium-doped yttrium aluminum garnet (Nd:YAG) posterior capsulotomy
Warnings
Do not use apraclonidine ophthalmic if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.
What other drugs will affect Apraclonidine ophthalmic
Using this medicine while you are taking other medications that make you sleepy can worsen this effect. Ask your doctor before using apraclonidine if you also take a sleeping pill, narcotic pain medicine, muscle relaxer, or medicine for anxiety, depression, or seizures.
Tell your doctor about all your current medicines and any you start or stop using, especially:
This list is not complete. Other drugs may interact with apraclonidine ophthalmic, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions